Despite previous findings of the neuroprotective role of adiponectin [33] and its potential as a diagnostic biomarker [10], our results suggest that plasma adiponectin level does not reflect the current status of the brain or AD pathology. The gene discussed is ADIPOQ; the disease is Alzheimer disease.